Cargando…
Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation
Combination therapy is an emerging strategy that is under intensive preclinical investigation for the treatment of various diseases. CD98 is highly overexpressed on the surfaces of epithelial cells and macrophages in the colon tissue with ulcerative colitis (UC), which is usually associated with muc...
Autores principales: | Xiao, Bo, Zhang, Zhan, Viennois, Emilie, Kang, Yuejun, Zhang, Mingzhen, Han, Moon Kwon, Chen, Jiucun, Merlin, Didier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135446/ https://www.ncbi.nlm.nih.gov/pubmed/27924161 http://dx.doi.org/10.7150/thno.15710 |
Ejemplares similares
-
Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans
por: Viennois, Emilie, et al.
Publicado: (2017) -
Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis
por: Zhang, Mingzhen, et al.
Publicado: (2018) -
Differential relieving effects of shikonin and its derivatives on inflammation and mucosal barrier damage caused by ulcerative colitis
por: Han, Hongwei, et al.
Publicado: (2021) -
PepT1 Expression Helps Maintain Intestinal Homeostasis by Mediating the Differential Expression of miRNAs along the Crypt-Villus Axis
por: Zhang, Yuchen, et al.
Publicado: (2016) -
Critical Role of PepT1 in Promoting Colitis-Associated Cancer and Therapeutic Benefits of the Anti-inflammatory PepT1-Mediated Tripeptide KPV in a Murine Model
por: Viennois, Emilie, et al.
Publicado: (2016)